Assertio (ASRT) COO exits stock, options and RSUs in $23.50-per-share cash merger
Rhea-AI Filing Summary
Assertio Holdings, Inc. President and COO Paul Schwichtenberg reported dispositions of his equity awards in connection with Assertio’s merger with Zydus entities. A tender offer for all Assertio common shares closed at an Offer Price of $23.50 per share in cash, followed by a merger making Assertio a wholly owned subsidiary.
Schwichtenberg disposed of 13,987 shares of common stock and multiple stock option grants and restricted stock units that were cancelled at the merger’s effective time. Unvested restricted stock units became fully vested and were converted into the right to receive cash at $23.50 per share, and in-the-money stock options were cancelled for a cash payment based on the spread between the offer price and each option’s exercise price. Out-of-the-money options were cancelled without payment, and his reported positions in these awards fell to zero.
Positive
- None.
Negative
- None.
Insights
Executive equity awards were cashed out or cancelled as Assertio was taken private via a tender offer and merger.
The filing shows President and COO Paul Schwichtenberg disposing of common shares, stock options, and restricted stock units due to Assertio’s acquisition. The tender offer paid $23.50 per share in cash for all outstanding common stock before the merger closed.
Unvested RSUs became fully vested just before the effective time and then converted into cash at the offer price, while in-the-money stock options were cancelled for a cash payment equal to the offer price minus each option’s exercise price, times the option share count.
Options with exercise prices at or above $23.50 were cancelled without payment, and the filing shows Schwichtenberg’s reported holdings in these awards dropping to zero. This reflects the standard clean-up of executive equity when a company becomes a wholly owned subsidiary in a cash acquisition, rather than open‑market trading.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Restricted Stock Units | 32,042 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 15,666 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 22,666 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 12,591 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 27,888 | $0.00 | -- |
| U | Common Stock | 13,987 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent ("Purchaser") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the "Offer") for all outstanding shares of common stock of the Issuer ("Company Common Stock") at a price of $23.50 per share in cash, without interest (the "Offer Price"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"), effective as of June 16, 2026 (the "Effective Time"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2] [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes. Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price. Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof.